Leveraging shear stress to bust clots with nanoparticles

Science

Volumn 337, Issue 6095, 2012, Pages 658-659

  Lavik, Erin ^a   Ustin, Jeffrey ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; POLYGLACTIN; STREPTAVIDIN; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

BLOOD; DRUG; NANOTECHNOLOGY; SHEAR STRESS; STROKE;

BLEEDING; BLOOD CLOT LYSIS; BLOOD FLOW; DRUG DELIVERY SYSTEM; DRUG TARGETING; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SHEAR STRESS; SHORT SURVEY; STROKE; ANIMAL; MALE; MESENTERIC BLOOD VESSEL OCCLUSION; METHODOLOGY; NOTE; THROMBOSIS;

ANIMALS; DRUG DELIVERY SYSTEMS; FIBRINOLYTIC AGENTS; MALE; MESENTERIC VASCULAR OCCLUSION; NANOPARTICLES; PULMONARY EMBOLISM; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84864843549     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1227097     Document Type: Short Survey

References (12)

1. J. Grotta, J. Marler, Surg. Neurol. 68 (suppl. 1), S12 (2007).
2. N. Korin et al., Science 337, 738 (2012); 10.1126/science.1217815.
3. D. Collen, H. R. Lijnen, Arteriosclerosis 4, 579 (1984).
4. J. M. Wardlaw, V. Murray, E. Berge, G. J. Del Zoppo, Cochrane Database Syst. Rev. 4, CD000213 (2009).
5. S. S. Wang, N. K. Chou, T. W. Chung, J. Biomed. Mater. Res. A 91A, 753 (2009).
6. T. W. Chung, S. S. Wang, W. J. Tsai, Biomaterials 29, 228 (2008).
7. C. Balucani, A. V. Alexandrov, Curr. Cardiol. Rep. 12, 34 (2010).
8. V. L. Roger et al., Circulation 125, 188 (2012).
9. D. Mukherjee, C. G. Patil, World Neurosurg. 76 (suppl.), S85 (2011).
10. M. D. Silverstein et al., Arch. Intern. Med. 158, 585 (1998).
11. A. Kibos, A. Guerchicoff, Acute Card. Care 13, 136 (2011).
12. M. N. Holme et al., Nat. Nanotechnol. 10.1038/nnano.2012.84 (2012).